Altamira Therapeutics Ltd... (EARS)
NASDAQ: EARS
· Real-Time Price · USD
3.04
-0.06 (-1.94%)
At close: Jul 26, 2021, 6:00 AM
Altamira Therapeutics Revenue
Altamira Therapeutics reported an annual revenue of $0, reflecting a undefined% growth. For the quarter ending June 30, 2023, Altamira Therapeutics generated $52.73K in revenue.
Revenue (ttm)
n/a
Revenue Growth
n/a
Price / Sales Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.21M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | -100.00% |
| Dec 31, 2022 | 305.62K | +378.41% |
| Dec 31, 2021 | 63.88K | -63.39% |
| Dec 31, 2020 | 174.47K | +-411.56% |
| Dec 31, 2019 | -56K | -104.42% |
| Dec 31, 2018 | 1.27M | +293.17% |
| Dec 31, 2017 | 322K | +-177.78% |
| Dec 31, 2016 | -414K | -517.91% |
| Dec 31, 2015 | -67K | -Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |